PHARMACOKINETICS OF SALICYLATE ELIMINATION IN MAN

[1] ALPEN EL, 1951, J PHARMACOL EXP THER, V102, P150

[2] BRODIE B B, 1959, Med Exp Int J Exp Med, V1, P290

[3] BURNS JJ, 1965, ANN NY ACAD SCI, V123, P273

[4] CHILDS B, 1959, PEDIATRICS, V23, P903

[5] FACTORS INFLUENCING PLASMA SALICYLATE CONCENTRATION + URINARY SALICYLATE EXCRETION AFTER ORAL DOSAGE WITH ASPRIIN [J]. BIOCHEMICAL PHARMACOLOGY, 1964, 13 (05) : 767 - &

[6] CUMMINGS AJ, 1963, SALICYLATES INTERNAT, P23

[7] DIXON ASJ, 1963, SALICYLATES INTERNAT, P23

[8] DIXON ASJ, 1963, SALICYLATES INTERNAT, P28

[9] DIXON ASJ, 1963, SALICYLATES INTERNAT, P9

[10] DONE AK, 1960, PEDIATRICS, V26, P800

[1] ALPEN EL, 1951, J PHARMACOL EXP THER, V102, P150

[2] BRODIE B B, 1959, Med Exp Int J Exp Med, V1, P290

[3] BURNS JJ, 1965, ANN NY ACAD SCI, V123, P273

[4] CHILDS B, 1959, PEDIATRICS, V23, P903

[5] FACTORS INFLUENCING PLASMA SALICYLATE CONCENTRATION + URINARY SALICYLATE EXCRETION AFTER ORAL DOSAGE WITH ASPRIIN [J]. BIOCHEMICAL PHARMACOLOGY, 1964, 13 (05) : 767 - &

[6] CUMMINGS AJ, 1963, SALICYLATES INTERNAT, P23

[7] DIXON ASJ, 1963, SALICYLATES INTERNAT, P23

[8] DIXON ASJ, 1963, SALICYLATES INTERNAT, P28

[9] DIXON ASJ, 1963, SALICYLATES INTERNAT, P9

[10] DONE AK, 1960, PEDIATRICS, V26, P800